Signs of immediate and delayed secondary toxicity have been examined in various systems of polychemical therapy undergone by 39 patients suffering from 'small cell lung cancer' (SCLC) and 72 with 'non-small cell lung cancer' (NSCLC). As to the therapeutic response, NSCLC cases are better treated with low-toxicity, well tolerated drugs. On the other hand, in SCLC cases which respond well to therapy, secondary toxicity is acceptable, given the patients' increased chances of survival.
|Translated title of the contribution||Immediate and delayed secondary toxicity of various systems of polychemical therapy of lung cancer at the third inoperable stage|
|Number of pages||6|
|Publication status||Published - 1981|
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine